Extensive superior limbic keratoconjunctivitis in Graves' disease: case report and mini-review of the literature.
Détails
ID Serval
serval:BIB_4A37FA8FA666
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Extensive superior limbic keratoconjunctivitis in Graves' disease: case report and mini-review of the literature.
Périodique
Clinical Ophthalmology
ISSN
1177-5467 (Print)
ISSN-L
1177-5467
Statut éditorial
Publié
Date de publication
03/2015
Peer-reviewed
Oui
Volume
9
Pages
467-468
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: epublish
Résumé
BACKGROUND: Superior limbic keratoconjunctivitis (SLK) is characterized as an inflammation of the superior bulbar conjunctiva with predominant involvement of the superior limbus and adjacent epithelial keratitis.
METHODS: A 51-year-old woman, with a history of medically controlled Graves' disease was seen with an extensive SLK involving 5 mm of the superior cornea.
RESULTS: Total remission was observed with topical steroids (DXM). Recurrence was observed 1 week after steroid discontinuation, and steroidal treatment was reintroduced with tapering over 1 month. Total remission was then observed for 1 year.
CONCLUSION: Extensive keratitis and vascular pannus in SLK is rarely reported. This form could be treated with topical steroids. Tapering treatment remains essential for long-term success.
METHODS: A 51-year-old woman, with a history of medically controlled Graves' disease was seen with an extensive SLK involving 5 mm of the superior cornea.
RESULTS: Total remission was observed with topical steroids (DXM). Recurrence was observed 1 week after steroid discontinuation, and steroidal treatment was reintroduced with tapering over 1 month. Total remission was then observed for 1 year.
CONCLUSION: Extensive keratitis and vascular pannus in SLK is rarely reported. This form could be treated with topical steroids. Tapering treatment remains essential for long-term success.
Pubmed
Web of science
Open Access
Oui
Création de la notice
02/02/2016 18:44
Dernière modification de la notice
20/08/2019 14:57
Données d'usage
